Organon (OGN) Other Working Capital Changes (2020 - 2026)
Organon (OGN) posted quarterly Other Working Capital Changes of -$16.0 million for Q2 2026, up 80.25% year-over-year from -$8.9 million in Q2 2025, and down 100.0% on a QoQ basis from -$8.0 million in Q1 2026.
Organon (OGN) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Organon has reported Other Working Capital Changes for 7 years, with the latest figure at -$16.0 million in Q2 2026.
- Other Working Capital Changes for Q2 2026 came in at -$16.0 million, up 80.25% year-over-year; the trailing twelve-month figure through Jun 2026 was -$42.0 million (up 65.0% YoY), and the FY2025 annual result was -$139.0 million, down 379.31% from the prior year.
- Other Working Capital Changes retreated to -$16.0 million in Q2 2026, from -$8.0 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $99.0 million in Q2 2024 and troughed at -$46.0 million in Q4 2023.
- A 5-year average of $24.2 million and a median of $24.0 million in 2024 frame the typical range for Other Working Capital Changes.
- The widest annual swing landed in 2022, when Other Working Capital Changes surged 180.0%; it then plunged 912.5% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $16.0 million in 2022, then soared by 131.25% to $37.0 million in 2023, then grew by 2.7% to $38.0 million in 2024, then sank by 126.32% to -$10.0 million in 2025, then plunged by 60.0% to -$16.0 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$16.0 million in Q2 2026, -$8.0 million in Q1 2026, and -$10.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.50 Bn | 631.74 Bn | 17.26 Bn |
| 2 | AbbVie | 469.68 Bn | 463.11 Bn | 12.70 Bn |
| 3 | Merck | 375.54 Bn | 368.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.20 Bn | 295.51 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.76 Bn | 252.86 Bn | 12.86 Bn |
| 6 | Amgen | 236.70 Bn | 222.71 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.32 Bn | 179.14 Bn | 6.22 Bn |
| 8 | Pfizer | 159.56 Bn | 147.86 Bn | 10.94 Bn |
| 9 | Gsk | 106.15 Bn | 101.98 Bn | 8.24 Bn |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76.00 Mn |
| Jun 30, 2026 | 76.00 Mn |
| Jun 30, 2026 | 76.00 Mn |
| Mar 31, 2026 | 15.00 Mn |
| Mar 31, 2026 | 15.00 Mn |
| Mar 31, 2026 | 15.00 Mn |
| Dec 31, 2025 | -22.00 Mn |
| Dec 31, 2025 | -22.00 Mn |
| Dec 31, 2025 | -22.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Jun 30, 2025 | 67.00 Mn |
| Jun 30, 2025 | 67.00 Mn |
| Jun 30, 2025 | 67.00 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Dec 31, 2024 | 56.00 Mn |
| Dec 31, 2024 | 56.00 Mn |